Methodology for protein-ligand binding studies: application to a model for drug resistance, the HIV/FIV protease system.
A protocol for the rapid energetic analysis of protein-ligand complexes has been developed. This protocol involves the generation of protein-ligand complex ensembles followed by an analysis of the binding free energy components. We apply this methodology toward understanding the origin of binding specificity within the human immunodeficiency virus/feline immunodeficiency virus (HIV/FIV) protease system, a model system for drug resistance studies. A distinct difference in the internal strain of an inhibitor within each protein environment clearly favors the HIV protease complex, as observed experimentally. Our analysis also predicts that residues within the S2-S3 pockets of the FIV protease active site are responsible for this strain. Close examination of the active site residue contributions to interaction energy and desolvation energy identifies specific amino acids that may also play a role in determining the binding preferences of these two enzymes. Proteins 1999;36:318-331.
Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
B N
BN
Dominy
C L
CL
Brooks
D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000737:chemistry* / Q000378:metabolism; D020134:Catalytic Domain; D002415:Cats; D004352:Drug Resistance, Microbial; D016333:HIV Protease / Q000737:chemistry* / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D016089:Immunodeficiency Virus, Feline / Q000201:enzymology*; D008024:Ligands; D008954:Models, Biological; D011485:Protein Binding; D055672:Static Electricity; D013816:Thermodynamics
D017320:HIV Protease Inhibitors; D008024:Ligands; D016282:Aspartic Acid Endopeptidases; C095555:FIV protease; D016333:HIV Protease